FDANonrulemakingFDA-2024-D-4624
Who commented on this docket
Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics; Draft Guidance for Industry; Availability
1 organizations filed 1 public comment on Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 560d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 560d ago
Commenters (1)
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.